ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,775, issued on June 9, was assigned to OP-T LLC (Aurora, Colo.).
"CD154 peptides and methods of reducing inflammation" was invented by David Wagner (Denver).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods and materials for treating and preventing autoimmune diseases. In particular, the present invention relates to the discovery that small peptides are capable of interacting with CD40, thereby interfering with the ability of CD40 to interact with CD154, which is important in inflammation. The present invention also relate to the use of such peptides in reducing the inflammatory response, and in particular, the auto...